1. Adduci A, Jankovic M, Strazzer S, Massimino M, Clerici C, Poggi G. Parent-child
communication and psychological adjustment in children with a brain tumor. Pediatr
Blood Cancer. 2012 Aug;59(2):290-4.
2. Ajovalasit D, Vago C, Usilla A, Riva D, Fidani P, Serra A, Gentile S, Massimino M,
Biassoni V, Leonardi M. Use of ICF to describe functioning and disability in children
with brain tumours. Disabil Rehabil. 2009;31 Suppl 1:S100-7
3. Antonelli M, Massimino M, Morra I, Garrè ML, Gardiman MP, Buttarelli FR, Arcella
A, Giangaspero F. Expression of pERK and pAKT in pediatric high grade
astrocytomas: correlation with YKL40 and prognostic significance. Neuropathology.
2012 Apr;32(2):133-8.
4. Benesch M, Frappaz D, Massimino M. Spinal cord ependymomas in children and
adolescents. Childs Nerv Syst. 2012 Dec;28(12):2017-28
5. Beretta S, Polastri D, Clerici CA, Casanova M, Cefalo G, Ferrari A, Luksch R,
Massimino M, Meazza C, Podda MG, Spreafico F, Terenziani M, Bellani FF. End
of life in children with cancer: experience at the pediatric oncology department of
the istituto nazionale tumori in Milan. Pediatr Blood Cancer. 2010 Jan;54(1):88-91
6. Biassoni V, Casanova M, Spreafico F, Gandola L, Massimino M. A case of
relapsing glioblastoma multiforme responding to vinorelbine. J Neurooncol 80:195201, 2006
7. Biassoni V, Pallotti F, Spreafico F, Seregni E, Gandola L, Martinetti A, Massimino
M. A female survivor of childhood medulloblastoma presentino with growthhormone-induced edema and inflammatory lesions: a case report. J Med Case
Reports. 2009 Jan 16;3:17
8. Bode U, Massimino M, Bach F, Zimmermann M, Khuhlaeva E, Westphal M,
Fleischhack G. Nimotuzumab treatment of malignant gliomas. Expert Opin Biol
Ther. 2012 Dec;12(12):1649-59.
9. Bouffet E, Perilongo G, Canete A, Massimino M. (position paper) Intracranial
ependymomas in children: a critical review of prognostic factors and a plea for
cooperation. Med Ped Oncol 1998; 30: 319-331
10. Buttarelli FR, Massimino M, Antonelli M, Lauriola L, Nozza P, Donofrio V, Arcella
A, Oliva MA, Di Rocco C, Giangaspero F. Evaluation status and prognostic
significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter
methylation in pediatric high grade gliomas. Childs Nerv Syst. 2010
Aug;26(8):1051-6.
11. Casanova M, Ferrari A, Spreafico F, Luksch R, Terenziani M, Cefalo G, Massimino
M, Gandola L, Lombardi F, Fossati-Bellani F. Malignant peripheral nerve sheath
tumors on children: a single-institution twenty-yera experience. J Ped Hematol
Oncol 1999; 21: 509-513
12. Casanova M, Ferrari A, Spreafico F, Terenziani M, Massimino M, Luksch R, Cefalo
G, Polastri D, Marcon I, Fossati Bellani F. Vinorelbine in previously treated
advanced childhood sarcomas. Cancer 94:3263-3268, 2002
13. Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R,
Cefalo G, Terenziani M, Polastri D, Fossati Bellani F, Mazzaferro V. Etoposide,
cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors. Pediatr
Hematol Oncol 22:189-198, 2005
14. Castellani MR, Rottoli L, Maffioli L, Massimino M, Gasparini M, Buraggi Gl.
Experience with palliative 131I Metaiodo benzylguanidine therapy in advanced
neuroblastoma. J Nucl Biol Med 1991; 35: 241-243
15. Cefalo G, Ferrari A, Tesoro-Tess JD, Gianni MC, Fossati-Bellani F, Lombardi F,
Massimino M. Treatment of childhood post-irradiation sarcoma of bone cancer
survivors. Med Ped Oncol 1997; 29: 568-572
16. Cetica V, Genitori L, Giunti L, Sanzo M, Bernini G, Massimino M, Sardi I. Pediatric
brain tumors: mutations of two dioxygenases (hABH2 and hABH3) that directly
repair alkylation damage. J Neurooncol. 2009 Sep;94(2):195-201. Epub 2009 Mar
17
17. Clerici C.A., Massimino M., Casanova M., Cefalo G., Terenziani M., Vasquez R.,
Meazza C., Ferrari A.: Psychological referral and consultation for adolescents and
young adults with cancer treated at pediatric oncology unit. Pediatr Blood Cancer;
51: 105-109, 2008
18. Clerici CA, Ferrari A, Luksch R, Casanova M, Massimino M, Cefalo G, Terenziani
M, Spreafico F, Polastri D, Fossati-Bellani F. Clinical experience with psychological
aspects in pediatric patients amputated for malignancies. Tumori 90:399-404, 2004
19. Clerici CA, Ferrari A, Massimino M, Luksch R, Cefalo G, Terenziani M, Casanova
M, Spreafico F, Polastri D, Fossati-Bellani F. Aspetti psicologici dei pazienti
amputati in età pediatrica per malattie neoplastiche. Ital J Pediatr 2001; 27: 887-892
20. Clerici CA, Ferrari A, Massimino M, Luksch R, Cefalo G, Terenziani M, Casanova
M, Spreafico F, Polastri D, Meazza C, Podda MG, Fossati Bellani F. Assistance to
parents who have lost their child with cancer. Tumori 92:306-310, 2006
21. Clerici CA, Ferrari A, Massimino M, Terenziani M, Casanova M, Luksch R,
Spreafico F, Cefalo G, Polastri D, Fossati-Bellani F, Albasi C, Gelli P.Five questions
for assessing psychological problems in pediatric patients cured of neoplastic
disease. Pediatr Hematol Oncol 21:481-7, 2004
22. Clerici CA, Ferrari A, Simonetti F, Massimino M. Psychotherapy and
psychopharmacology for mental health in adolescents with cancer: what integration
is possible? Expert Rev Anticancer Ther. 2011 Nov;11(11):1623-5
23. Clerici CA, Ferrari A, Veneroni L, Casiraghi G, Giacon B, Armiraglio M, Massimino
M. At least we can send some flowers...Tumori. 2012 Sep-Oct;98(5):146e-148e.
24. Clerici CA, Fossati Bellani F, Lepera P, Gennaro M, Bergonzi S, Meazza C, Podda
M, Gandola L, Veneroni S, Casanova M, Cefalo G, Ferrari A, Luksch R, Massimino
M, Polastri D, Spreafico F, Terenziani M. Psychological assessment of women on
an early breast screening program after radiotherapy to the chest wall for childhood
cancer. Tumori; 94: 568-573, 2008
25. Clerici CA, Giacon B, Polastri D, Simonetti F, Veneroni L, Ferrari A, Massimino
M.Psychopharmacology and psychotherapy in pediatric oncology. Update and
perspectives of integration. Recenti Prog Med. 2011 Jul-Aug;102(7-8):314-20. doi:
10.1701/913.10053. Review. Italian.
26. Clerici CA, Simonetti F, Massimino M, Fossati Bellani F: Antidepressants in
pediatric oncology. (Letter) Pediatr Blood Cancer; 50: 1290-1291, 2008
27. Clerici CA, Spreafico F, Cavallotti G, Consoli A, Veneroni L, Sala A, Massimino M.
Mirror therapy for phantom limb pain in an adolescent cancer survivor. Tumori.
2012 Jan-Feb;98(1):e27-30. do
28. Collini P, Massimino M, Leite SF, Mattavelli F, Seregni E, Zucchini N, Spreafico F,
Ferrari A, Castellani MR, Cantu G, Fossati-Bellani F, Rosai J. Papillary thyroid
carcinoma of childhood and adolescence: A 30-year experience at the Istituto
Nazionale Tumori in Milan. Pediatr Blood Cancer 46:300-306, 2006
29. Collini P, Mattavelli F, Pellegrinelli A, Barisella M, Ferrari A, Massimino M. Papillary
carcinoma of the thyroid gland of childhood and adolescence: Morphologic
subtypes, biologic behavior and prognosis. A clinicopathologic study of 42 sporadic
cases treated at a single institution during a 30-year period. Am J Surg Pathol
30:1420-1426, 2006
30. Collini P, Mattavelli F, Spinelli C, Massimino M. Treatment of sporadic
nonmedullary thyroid carcinomas in pediatric age. Expert Rev Anticancer Ther.
7:23-30. 2007
31. Cordaro G, Veneroni L, Massimino M, Clerici CA. Assessing psychological
adjustment in siblings of children with cancer: parents' perspectives. Cancer Nurs.
2012 Jan-Feb;35(1):E42-50.
32. Di Nicola M, Carlo-Stella C, Mariotti I, Devizzi L, Massimino M, Cabras A, Magni M,
Matteucci P, Guidetti A, Gandola L, Gianni AM. High response rate and
manageable toxicity with an intensive, short-term chemotherapy for Burkitt’s
lymphoma in adults. Brit J Hematol 2004; 126: 815-820
Elenco lavori in extenso. Dr.ssa Maura Massimino
33. Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T,
Frappaz D, Massimino M, Grill J, Boyett JM, Grundy RG. Histopathological grading
of pediatric ependymoma: reproducibility and clinical relevance in European trial
cohorts. J Negat Results Biomed. 2011 May 31;10:7
34. Fangusaro J, Massimino M, Rutkowski S, Gururangan S. Non-cerebellar primitive
neuroectodermal tumors (PNET): summary of the Milan consensus and state of the
art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for
malignant brain tumors of childhood and adolescents. Pediatr Blood Cancer. 2010
Apr;54(4):638-40
35. Favini F, Massimino M, Esposito V, Maestri L, Fava G, Spreafico F. Rectal Burkitt
lymphoma in childhood. J Pediatr Hematol Oncol 2008; 30: 176-178
36. Ferrari A, Casanova M, Collini P, Meazza C, Luksch R, Massimino M, Cefalo G,
Terenziani M, Spreafico F, Catania S, Gandola L, Gronchi A, Mariani L, FossatiBellani F. Adult-type soft tissue sarcomas in pediatric age: experience at the Istituto
Nazionale Tumori in Milan. J Clin Oncol 23:4021-4030, 2005
37. Ferrari A, Casanova M, Massimino M, Luksch R, Cefalo G, Lombardi F, Galimberti
S, Riganti G, Fossati-Bellani F. Synovial sarcoma: report of a series of 25
consecutive children from a single institution. Med Ped Oncol 1999; 32: 32-37
38. Ferrari A, Casanova M, Massimino M, Luksch R, Piva L, Fossati-Bellani F. The
management of paratesticular rhabdomyosarcoma: a single institutional experience
with 44 consecutive children. J Urol 1998; 159: 1031-1034
39. Ferrari A, Casanova M, Massimino M, Sultan I. Peculiar features and tailored
management of adult cancers occurring in pediatric age. Expert Rev Anticancer
Ther. 2010 Nov;10(11):1837-51.
40. Ferrari A, Casanova M, Spreafico F, Luksch R, Terenziani M, Cefalo G, Massimino
M, Gandola L, Navarria P, Fossati-Bellani F. Childhood liposarcoma: a singleinstitutional twenty-year experience. Ped Hematol Oncol 1999; 16: 415-421
41. Ferrari A, Clerici CA, Casanova M, Luksch R, Terenziani M, Spreafico F, Polastri D,
Meazza C, Veneroni L, Catania S, Schiavello E, Biassoni V, Podda M, Massimino
M. The Youth Project at the Istituto Nazionale Tumori in Milan. Tumori. 2012 JulAug;98(4):399-407
42. Ferrari A, Clerici CA, Spreafico F, Casanova M, Massimino M, Luksch R,
Terenziani M, Cefalo G, Polastri D, Fossati-Bellani F. Psychological support in
children and adolescents with cancer when amputation is required (Proceedings of
the Tumor Board of the Pediatric Oncology Unit of the Istituto Nazionale Tumori,
Milano, Italy). Med Pediatr Oncol 38:261-265, 2002
43. Ferrari A, Fabietti P, Vessecchia G, Laffranchi A, Lombardi L, Massimino M,
Fossati-Bellani F, Giardini R. Langerhans cell histioytosis arising after Hodgkin’s
disaese. Ped Hematol Oncol 1997; 14: 585-588
44. Ferrari A, Meazza C, Casanova M, Luksch R, Spreafico F, Massimino M,
Terenziani M, Polastri D, Cefalo G, Gandola L, Gronchi A, Fossati-Bellani F.
Sarcoma sinoviale in età pediatrica. Esperienza dell’Istituto Nazionale Tumori di
Milano. Ital J Pediatr 2001; 27: 869-875
45. Ferrari A, Miceli R, Casanova M, Gronchi A, Collini P, Meazza C, Zaffignani E,
Massimino M, Spreafico F, Mariani L. Adult-type soft tissue sarcomas in pediatric
age: A nomogram-based prognostic comparison with adult sarcoma. Eur J Cancer
2007; 43: 2691-2697
46. Ferrari A, Miceli R, Meazza C, Casanova M, Favini F, Morosi C, Trecate G,
Marchianò A, Luksch R, Cefalo G, Terenziani M, Spreafico F, Polastri D, Podda M,
Catania S, Schiavello E, Giannatempo P, Gandola L, Massimino M, Mariani L.
Comparison of the prognostic value of assessing tumor diameter versus tumor
volume at diagnosis or in response to initial chemotherapy in rhabdomyosarcoma. J
Clin Oncol. 2010 Mar 10;28(8):1322-8. Epub 2010 Feb 1
47. Ferrari A, Miceli R, Meazza C, Zaffignani E, Gronchi A, Piva L, Collini P, Podda M,
Massimino M, Luksch R, Cefalo G, Terenziani M, Spreafico F, Polastri D, FossatiBellani F, Casanova M, Mariani L. Soft Tissue Sarcomas of Childhood and
Adolescence: The Prognostic Role of Tumor Size in Relation to Patient Body Size.
J Clin Oncol. 2009 Jan 20;27(3):371-376. Epub 2008 Dec
48. Ferrari A, Perotti D, Giardini R, Ghio L, Riva S, Massimino M. Disseminated
Burkitt’s lymphoma after kidney transplantation: a case report in a boy with Drash
syndrome. J Ped Hematol Oncol 1997; 19: 151-155
49. Ferrari A, Veneroni L, Clerici CA, Spreafico F, Terenziani M, Massimino M, Luksch
R, Casanova M, Meazza C, Polastri D, Gandola L. Adolescents with cancer: the
"Youth Project" at the Istituto Nazionale Tumori in Milan. Recenti Prog Med. 2013
Jan;104(1):10-6
50. Finlay JL, Massimino M. A consensus and state-of-the-art workshop: marrow
ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of
childhood and adolescence. Pediatr Blood Cancer. 2010 Apr;54(4):634
51. Fossati-Bellani F, Massimino M. Liver tumors in childhood: epidemiology and
clinics. J Surg Oncol Suppl 1993; 3: 119-121
52. Gandola L, Massimino M, Cefalo G, Solero C, Spreafico F, Pecori E, Riva D,
Collini P, Pignoli E, Giangaspero F, Luksch R, Berretta S, Poggi G, Biassoni V,
Ferrari A, Pollo B, Favre C, Sardi I, Terenziani M, Fossati-Bellani F.
Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic
Medulloblastoma. J Clin Oncol. 2009 Feb 1;27(4):566-71
53. Garrè ML, Cama A, Milanaccio C, Gandola L, Massimino M, Dallorso S. New
Concepts in the Treatment of brain tumors in very young children. Expert Rev
Neurother 6:489-500, 2006
54. Garrè ML, Cama A, Morana G, Bagnasco F, Giangaspero F, Brisigotti M, Gambini
C, Forni M, Rossi A, Haupt R, Nozza P, Barra S, Piattelli G, Uccella C, Capra V,
Bruno W, Pastorino L, Massimino M, Tumolo M, Milanaccio C, Dallorso S, and
Pietsch T. Medulloblastoma Variants: Age-Dependent Occurrence And Relation To
Gorlin Syndrome: A New Clinical Perspective. Clinical Cancer Research, in press
55. Gasparini M, Lombardi F, Ballerini E, Gandola L, Gianni MC, Massimino M, Rottoli
L, Fossati-Bellani F. Long-term out come of patients with monostotic Ewing’s
sarcoma treated with combined modality. Med Ped Oncol 1994; 23: 406-412
56. Gasparini M, Lombardi F, Gianni MC, Massimino M, Gandola L, Fossati-Bellani F.
Questionable Role of CNS radioprophylaxis in the therapeutic management o
childhood rhabdomyosarcoma with meningeal extension. J Clin Oncol 1990; 8:
1854-1857
57. Gasparini M, Rottoli L. Massimino M, Gianni MC, Ballerini E, Ravagnani F, Pupa S,
Fossati-Bellani F. Curability of advanced Burkitt’s lymphoma in children by intensive
short-term chemotherapy. Eur J Cancer 1993, 29A: 692-698
58. Gasparini P, Facchinetti F, Boeri M, Lorenzetto E, Livio A, Gronchi A, Ferrari A,
Massimino M, Spreafico F, Giangaspero F, Forni M, Maestro R, Alaggio R, Pilotti
S, Collini P, Modena P, Sozzi G. Prognostic determinants in epithelioid sarcoma.
Eur J Cancer. 2011 Jan;47(2):287-95
59. Gessi m, Maderna E, Guzzetti S, Cefalo G, Massimino M, Solero CL, Finocchiaro
G, Pollo B. Radiation-induced glioblastoma in a medulloblastoma patient: a case
report with molecular features. Neuropathology 2008;
60. Giannelli U, Patriarca C, Moro A, Ponzoni M, Giardini R, Massimino M , Alfano RM,
Armiraglio E, Nuciforo P, Bosari S, Coggi G, Parafioriti A. Lymphomas of the bone:
A pathological and clinical study of 54 cases. Int J Surg Pathol 10:257-266, 2002
61. Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino
M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T,
Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford
SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R.
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in
standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP
PNET 4 trial. J Clin Oncol. 2012 Sep 10;30(26):3187-93.
62. Luksch R, Massimino M, Cefalo G, Lombardi F, Ferrari A, Casanova M, Gandola
L, Terenziani M, Spreafico F, Fossati-Bellani F. Effects of recombinant human
granulocyte-macrophage colony-stimulating factor in an intensive treatment
program for children with Ewing’s sarcoma. Haematologica 2001; 86: 753-760
63. Luksch R, Perotti D, Cefalo G, Gambacorti Passerini C, Massimino M, Spreafico F,
Casanova M, Ferrari A, Terenziani M, Polastri D, Gambirasio F, Podda M, Bozzi F,
Ravagnani F, Parmiani G, Fossati Bellani F. Immunomodulation in a treatment
program including pre- and post-operative interleukin-2 and chemotherapy for
childhood osteosarcoma. Tumori 89:263-268,2003
64. Luksch R, Podda M, Gandola L, Polastri D, Piva L, Castellani R, Collini P,
Massimino M, Cefalo G, Terenziani M, Ferrari A, Casanova M, Spreafico F,
Meazza C, Bozzi F, Marchiano A, Ravagnani F, Fossati-Bellani F. Stage 4
neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus
autologous haemopoietic stem cell transplantation to consolidate primary treatment.
Br J Cancer 92:1984-1988, 2005
65. Luksch R, Sampietro G, Collini P, Boracchi P, Massimino M, Lombardi F, Gandola
l, Giardini R, Fossati-Bellani F, Migliorini L, Pilotti S, Scopsi L. Prognostic value of
clinicopathologic characteristics including neuroectodermal differentiation in
osseous Ewing’s sarcoma family of tumors in children. Tumori 1999; 85: 101-107
66. Massimino M, Antonelli M, Gandola L, Miceli R, Pollo B, Biassoni V, Schiavello E,
Buttarelli FR, Spreafico F, Collini P, Giangaspero F. Histological variants of
medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood
Cancer. 2013 Feb;60(2):210-6
67. Massimino M, Biassoni V. Use of high-dose chemotherapy in front-line therapy of
childhood malignant glioma. Expert Rev Anticancer Ther 6:709-717, 2006
68. Bode U, Biassoni V, Fleischhack G. Nimotuzumab for pediatric diffuse intrinsic
pontine gliomas. Expert Opin Biol Ther. 2011 Feb;11(2):247-56.
69. Massimino M, Buttarelli FR, Antonelli M, Gandola L, Modena P, Giangaspero F.
Intracranial Ependymomas: factors affecting out come. Future Oncol. 2009
Mar;5(2):207-16. Review.
70. Massimino M, Casanova M, Polastri D, Biassoni V, Modena P, Pecori E,
Schiavello E, De Pava MV, Indini A, Rampini P, Bauer D, Catania S, Podda M,
Gandola L. Relapse in medulloblastoma: what can be done after abandoning highdose chemotherapy? A mono-institutional experience.Childs Nerv Syst. 2013 Apr
18.
71. Massimino M, Cefalo G, Riva D, Biassoni V, Spreafico F, Pecori E, Poggi G, Collini
P, Pollo B, Valentini L, Potepan P, Seregni E, Casanova M, Ferrari A, Luksch R,
Polastri D, Terenziani M, Pallotti F, Clerici CA, Schiavello E, Simonetti F, Meazza C,
Catania S, Podda M, Gandola L. Long-term results of combined preradiation
chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
J Neurooncol. 2012 May;108(1):163-71.
72. Massimino M, Cefalo G, Trecate G, Simonetti F. Sucking and recovery after braiun
surgery. J Clin Oncol 2001; 19: 273-278
73. Massimino M, Cohen KJ, Finlay JL. Is there a role for myeloablative chemotherapy
with autologous hematopoietic cell rescue in the management of childhood highgrade astrocytomas? Pediatr Blood Cancer. 2010 Apr;54(4):641-3. Review
74. Massimino M, Collini P, Leite SF, Spreafico F, Zucchini N, Ferrari A, Mattavelli F,
Seregni E, Castellani MR, Cantu G, Fossati-Bellani F, Rosai J. Conservative
surgical approach for thyroid and lymph-node involvement in papillary thyroid
carcinoma of childhood and adolescence. Pediatr Blood Cancer 46:307-313, 2006
75. Massimino M, Gandola L, Barra S, Giangaspero F, Casali C, Potepan P, Di Rocco
C, Nozza P, Collini P, Viscardi E, Bertin D, Biassoni V, Cama A, Milanaccio C,
Modena P, Balter R, Tamburrini G, Peretta P, Mascarin M, Scarzello G, Fidani P,
Milano GM, Sardi I, Genitori L, Garrè ML. Infant ependymoma in a 10-year AIEOP
(Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or
deferred radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):807-14Related
citations
76. Massimino M, Gandola L, Casanova M, Cefalo G, Ferrari A, Luksch R, Riganti G,
Lombardi F. Concomitant chemoradiotherapy for childhood poor prognosis glioma.
Med Pediatr Oncol 2000; 34; 147-150
77. Massimino M, Gandola L, Cefalo G, Lasio G, Riva D, Fossati-Bellani F, Gianni MC,
Luksch R, Tesoro-Tess JD, Lombardi F. Management of medulloblastoma and
ependymoma in infants: a single-institution long-term retrospective report. Child’s
Nerv Syst 2000; 16: 15-20
78. Massimino M, Gandola L, Collini P, Seregni E, Marchianò A, Serra A, Pignoli E,
Spreafico F, Pallotti F, Terenziani M, Biassoni V, Bombardieri E, Fossati-Bellani F:
Thyroid stimulating hormine suppression for protection againthypothyroidism due to
craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal
tumors. Int J Radiat Oncol Biol Phys 2007; 69: 404-410
79. Massimino M, Gandola L, Garrè ML, Modena P, Cama A, Potepan P, Giangaspero
F. Do we really need class 1 evidence results to give adjuvant radiation therapy to
childhood intracranial ependymomas? Comments to Childs Nerv Syst, Little AS, et
al. The management of completely resected childhood intracranial ependymoma:
the argument for observation only. Childs Nerv Syst. 2009 Jun;25(6):641-2; author
reply 643-4. Epub 2009 Apr 1
80. Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G,
Garrè ML, Ricardi U, Forni M, Genitori L, Scarzello G, Spreafico F, Barra S,
Mascarin M, Pollo B, Gardiman M, Cama A, Navarria P, Brisigotti M, Collini P,
Balter R, Fidani P, Stefanelli M, Burnelli R, Potepan P, Podda M, Sotti G, Madon E;
AIEOP Pediatric Neuro-Oncology Group. Hyperfractionated radiotherapy and
chemotherapy for childhood ependymoma: final results of the first prospective
AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J
Radiat Oncol Biol Phys 58:1336-1345, 2004
81. Massimino M, Gandola L, Luksch R, Spreafico F, Riva D, Solero C, Giangaspero
F, Locatelli F, Podda M, Bozzi F, Pignoli E, Collini P, Cefalo G, Zecca M, Casanova
M, Ferrari A, Terenziani M, Meazza C, Polastri D, Scaramuzza D, Ravagnani F,
Fossati-Bellani F. Sequential chemotherapy, high-dose thiotepa, circulating
progenitor cell rescue, and radiotherapy for childhood high-grade glioma. Neurooncol 7:41-48, 2005
82. Massimino M, Gandola L, Mattavelli F, Pizzi N, Seregni E, Pallotti F, Spreafico F,
Marchianò A, Terenziani M, Cefalo G, Biassoni V, Meazza C, Trecate G, Collini P.
Radiation-induced thyroid changes: a retrospective and a prospective view. Eur J
Cancer. 2009 Sep;45(14):2546-51. Epub 2009 Jul 14
83. Massimino M, Gandola L, Pignoli E, Seregni E, Marchianò A, Pecori E, Catania S,
Cefalo G.TSH suppression as a possible means of protection against
hypothyroidism after irradiation for childhood Hodgkins lymphoma. Pediatr Blood
Cancer. 2011 Jul 15;57(1):166-8
84. Massimino M, Gandola L, Seregni E, Bongarzone I, Morosi C, Collini P. Thyroid
iatrogenic sequelae after the treatment of pediatric cancer. Q J Nucl Med Mol
Imaging. 2009 Oct;53(5):526-35. Review
85. Massimino M, Gandola l, Spreafico F, Biassoni V, Luksch R, Collini P, Solero C,
Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda
M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D,
Ravagnani F, Fossati-Bellani F. No salvage using high-dose chemotherapy
plus/minus reirradiation for relapsing previous irradiated medulloblastoma. Int J
Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1358-63. Epub 2008 Nov 18
86. Massimino M, Gandola L, Spreafico F, Biassoni V, Terenziani M, Pecori E, Arcella
A, Giangaspero F. Unusual primary secreting germ cell tumor of the spine. J
Neurosurg Spine 5:65-67, 2006
87. Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F,
Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M,
Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F. Supratentorial
primitive neuroectodermal tumors (S-PNET) in children: A prospective experience
with adjuvant intensive chemotherapy and hyperfractionated accelerated
radiotherapy. Int J Radiat Oncol Biol Phys 64:1031-1037, 2006
88. Massimino M, Gasparini M, Ballerini E, Del Bo R. Primary carcinoma in children: a
retrospective study of 20 patients. Med Ped Oncol 1995; 24: 13-17
89. Massimino M, Gasparini M, Giardini R. Ki-1 (CD30) anaplastic large-cell lymphoma
in children. Ann Oncol 1995; 6: 915-920
90. F, Garrè ML, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S. Childhood
medulloblastoma. Crit Rev Oncol Hematol. 2011 Jul;79(1):65-83.
91. Massimino M, Giangaspero F, Garrè ML, Genitori L, Perilongo G, Collini P, Riva D,
Valentini L, Scarzello G, Poggi G, Spreafico F, Peretta P, Mascarin M, Modena P,
Sozzi G, Bedini N, Biassoni V, Urgesi A, Balestrini MR, Finocchiaro G, Sandri A,
Gandola L, for the AIEOP Pediatric Neuro-Oncology Group. Salvage treatment for
childhood ependymoma after surgery only: pitfalls of omitting “at once” adjuvant
treatment. Int J Radiat Oncol Biol Phys 65:1440-1445, 2006
92. Massimino M, Giardini R, Simonetti F, Pollo B, Giombini S, Tesoro-Tess JD,
Ponzoni M, Patriarca C. Intravascular lymphomatosis (IL) in a child mimicking a
posterior fossa tumor. J Neuro-Oncol 2001; 51: 47-50
93. Massimino M, Patriarca C. Verdi and death. Med Pediatr Oncol 38:260, 2002
94. Massimino M, Perotti D, Spreafico , Luksch R, Garaventa A, Giardini R. Non-ALC
peripheral T-cell lymphoma in children: report on two cases and a review of the
literature. Haematologica 2000; 85: 1109-1111
95. Massimino M, Simonetti F, Balestrini MR, Spreafico F, La Spina M, Terenziani M,
Gandola L. Transitory, sponteneously recovering, peripheral facial nerve palsy after
vinorelbine administration. Neurol Sci 27:110-113, 2006
96. Massimino M, Solero CL, Garrè ML, Biassoni V, Cama A, Genitori L, Di Rocco C,
Sardi I, Viscardi E, Modena P, Potepan P, Barra S, Scarzello G, Galassi E,
Giangaspero F, Antonelli M, Gandola L. Second-look surgery for ependymoma: the
Italian experience. J Neurosurg Pediatr. 2011 Sep;8(3):246-50.
97. Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, Giombini S,
a G, Pecori E, Pignoli E, Casanova M, Ferrari A, Meazza C, Luksch R, Terenziani
M, Cefalo G, Podda M, Polastri D, Clerici CA, Fossati-Bellani F, Gandola L. Diffuse
pontine gliomas in children: changing strategies, changing results? A monoinstitutional 20-year experience. J Neurooncol. 2008; 87:355-61. Epub 2008 Jan 24
98. Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva
D, Ruggiero A, Valentini L, Mazza L, Genitori L, Di Rocco C, Navarria P, Casanova
M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F.
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J
Clin Oncol 20:4209-4216, 2002
99. Massimino M, Spreafico F, Luksch R, Giardini R. Prognostic significance of p80
and visceral invovement in childhood CD30 anaplastic large cell lymphoma (ALCL).
Med Pediatr Oncol 2001: 37: 97-103
100. Massimino M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L,
Genitori L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA,
Catania S, Sardi I, Giangaspero F. A lower-dose, lower-toxicity cisplatin-etoposide
regimen for childhood progressive low-grade glioma. J Neurooncol. 2010
Oct;100(1):65-71.
101. Massimino M. Ependymoma. Orphanet Encyclopedia, February 2004
102. Massimino M. Fattori di crescita: linee guida in pediatria in Lettera Terapeutica
suppl 6/2000 Mediprint
103. Massimino M. Letter to the editor. J Neurosurg Pediatr. 2012 Jan;9(1):108
104. Mazza E, Spreafico F, Cefalo G, Scaramuzza D, Massimino M. Case report:
Pseudomonas aeruginosa-related intervertebral discitis in a young boy with
medulloblastoma. J Neuro-Oncol 68:245-248, 2004
105. Meazza C, Casanova M, Luksch R, Podda M, Favini F, Cefalo G, Massimino M,
Ferrari A. Prolonged 14-day continuous infusion of high-dose ifosfamide with an
external portable pump: feasibility and efficacy in refractory pediatric sarcoma.
Pediatr Blood Cancer. 2010 Oct;55(4):617-20
106. Meazza C, Ferrari A, Casanova M, Gandola L, Massimino M, Scaramuzza D,
Collini P, Luksch R, Spreafico F, Cefalo G, Polastri D, Terenziani M, Cantù G,
Fossati-Bellani
F.
Evolving
treatment
strategies
for
parameningeal
rhabdomyosarcoma: the experience of the Istituto Nazionale Tumori of Milan. Head
Neck 27:49-57, 2005
107. Meazza C, Ferrari A, Casanova M, Massimino M, Luksch R, Spreafico F, Cefalo
G, Terenziani M, Polastri D, Podda M, Catania S, Cereda S, Gandola L, FossatiBellani F, Cantù G. Rhabdomyosarcoma of the head and neck region: experience
at the Pediatric Unit of Istituto Nazionale Tumori, Milan. J Otolaryngol 35:53-59,
2006
108. Melchionda F, Spreafico F, Ciceri S, Lima M, Collini P, Pession A, Massimino M,
Radice P, Perotti D. A Novel WT1 Mutation in Familial Wilms Tumor. Pediatr Blood
Cancer. 2013 Mar 28.
109. Modena P, Buttarelli FR, Miceli R, Piccinin E, Baldi C, Antonelli M, Morra I,
Lauriola L, Di Rocco C, Garrè ML, Sardi I, Genitori L, Maestro R, Gandola L,
Facchinetti F, Collini P, Sozzi G, Giangaspero F, Massimino M. Predictors of
outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis.
Neuro Oncol. 2012 Nov;14(11):1346-56.
110. Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I,
Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R,
Schoenmakers EF, Massimino M, Sozzi G. Identification of tumor-specific
molecular signatures in intracranial ependymoma and association with clinical
characteristics. J Clin Oncol 24:5223-5233, 2006
111. Modena P, Sardi I, Brenca M, Giunti L, Buccoliero AM, Pollo B, Biassoni V,
Genitori L, Antonelli M, Maestro R, Giangaspero F, Massimino M. Case report:
long-term survival of an infant syndromic patient affected by atypical teratoidrhabdoid tumor. BMC Cancer. 2013 Mar 5;13:100
112. Moreno L, Pollack IF, Duffner PK, Geyer JR, Grill J, Massimino M, Finlay JL,
Zacharoulis S. Utility of cerebrospinal fluid cytology in newly diagnosed childhood
ependymoma. J Pediatr Hematol Oncol. 2010 Aug;32(6):515-8
113. Passoni L, Gallo B, Biganzoli E, Stefanoni R, Massimino M, Di Nicola M, Gianni
AM, Gambacorti-Passerini C. In vivo T-cell immune response against anaplastic
lymphoma kinase in patients with anaplastic large cell lymphomas. Haematologica
91:48-55, 2006
114. Pastore V, Colombo K, Villa F, Galbiati S, Adduci A, Poggi G, Massimino M,
Recla M, Liscio M, Strazzer S.Psychological and adjustment problems due to
acquired brain lesions in pre-school-aged patients. Brain Inj. 2013 Jun;27(6):677-84
115. Patriarca C, Orazi A, Massimino M, Luksch R. A cystic partially differentiated
nephroblastoma producing alfa-fetoprotein. Am J Ped Hematol/Oncol 1992; 14:
352-355
116. Perilongo G, Massimino M, Sotti G, Belfontali T, Masiero L, Rigobello L, Garrè L,
Carli M, Lombardi F, Solero C, Sainati L, Canale V, Brach del Prever A,
Giangaspero F, Andreussi L, Mazza C, Madon E. Analyses of prognostic factors in
a retrospective review of 92 children with ependymoma: Italian Pediaric NeuroOncology group. Med Ped Oncol 1997; 29: 79-85
117. Perotti D, Mondini P, Giardini R, Ferrari A, Massimino M, Gambirasio F, Pierotti
MA, fossati-Bellani F, Radice P. No evidence of WT1 involvement in a Burkitt’s
lymphoma in a patients with Denys-Drash syndrome. Ann Oncol 1998; 9: 627-631
118. Perotti D, Sozzi G, Ferrari A, Casanova M, Gamburasio F, Modini P, Mezzelani A,
Giardini R, Pettenella F, Papini D, Biondi A, Fossati-Bellani F, Massimino M
Cytogenetic and molecular characterization of T-cell acute lymphoblastic leukemia
as a second tumor after anaplastic large-cell lymphoma in a boy. Haematologica
1999; 84: 554-557
119. Pivetta E, Maule MM, Pisani P, Zugna D, Haupt R, Jankovic M, Aricò M, Casale F,
Clerico A, Cordero di Montezemolo L, Kiren V, Locatelli F, Palumbo G, Pession A,
Pillon M, Santoro N, Terenziani M, Valsecchi MG, Dama E, Magnani C, Merletti F,
Pastore G; Italian Association of Pediatric Hematology and Oncology (AIEOP)
Group.Marriage and parenthood among childhood cancer survivors: a report from
the Italian AIEOP Off-Therapy Registry. Haematologica. 2011 May;96(5):744-51.
120. Podda MG, Luksch R, Polastri D, Gandola L, Piva L, Collini P, Cefalo G,
Terenziani M, Ferrari A, Casanova M, Spreafico F, Meazza C, Castellani MR,
Catania S, Schiavello E, Marchianò A, Massimino M. Neuroblastoma in patients
over 12 years old: a 20-year experience at the Istituto Nazionale Tumori of Milan.
121. Poggi G, Liscio M, Adducci A, Galbiati S, Massimino M, Sommovigo M, Zettin M,
Figini E, Castelli E. Psychological and behavioral problems due to acquired brain
lesions in childhood: a comparison between post-traumatic patients and brain tumor
survivors. Brain Inj 19:777-785, 2005
122. Poggi G, Liscio M, Galbiati S, Adduci A, Massimino M, Gandola L, Spreafico F,
Clerici CA, Fossati-Bellani F, Sommovigo M, Castelli E. Brain tumors in children
and adolescents: cognitive and psychological disorders at different ages.
Psychooncology 14:386-395, 2005
123. Poggi G, Liscio M, Pastore V, Adduci A, Galbiati S, Spreafico F, Gandola L,
Massimino M. Psychological intervention in young brain tumor survivors: the
efficacy of the cognitive behavioural approach. Disabil Rehabil. 2009;31(13):106673
124. Riccardi A, Mazzarella G, Cefalo G, Garrè ML, Massimino M, Barone C, Sandri
A, Ridola V, Ruggiero A, Mastrangelo S, Lazzareschi I, Caldarelli M, Maira G,
Madon E, Riccardi R. Pharmacokinetics of temozolomide given three times a day
in pediatric and adult patients. Cancer Chemother Pharmacol 52:459-464, 2003
125. Riva D, Giorgi C, Nichelli F, Bulgheroni S, Massimino M, Cefalo G, Gandola L,
Giannnotta M, Bagnasco I, Saletti V, Pantaleoni C. Intrathecal methotrexate affects
cognitive function in children with medulloblastoma. Neurology 59:48-53, 2002
126. Riva D, Massimino M, Giorgi C, Nichelli F, Erbetta A, Usilla A, Vago C,
Bulgheroni S. Cognition before and after chemotherapy alone in children with
chiasmatic-hypothalamic tumors. J Neurooncol. 2008 Nov 14. [Epub ahead of print]
127. Riva D., Chiapparini L., Pollo B., Balestrini R., Massimino M, Milani N.: A case of
pediatric tumefactive demyelinating lesion misdiagnosed and treated as
glioblastoma. J Child Neurol 2008; 23: 944-947
128. Ruggiero A, Cefalo G, Garre ML, Massimino M, Colosimo C, Attina G,
Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Rocco CD, Madon
E, Abate ME, Clerico A, Sandri A, Riccardi R. Phase II trial of temozolomide in
children with recurrent high-grade glioma. J Neurooncol. 77:89-94, 2006
129. Sandri A, Massimino M, Mastrodicasa L, Sardi N, Bertin D, Basso ME, Todisco L,
Paglino A, Perilongo G, Genitori L, Valentini L, Ricardi U, Gandola L, Giangaspero
F, Madon E. Treatment with oral etoposide for childhood recurrent ependymomas J
Pediatr Hematol Oncol 27:486-490, 2005
130. Sardi I, Bresci C, Schiavello E, Biassoni V, Fratoni V, Cardellicchio S, Genitori L,
Aricò M, Massimino M. Successful treatment with a low-dose cisplatin--etoposide
regimen for patients with diencephalic syndrome. J Neurooncol. 2012
Sep;109(2):375-83
131. Sardi I, Cavalieri D, Massimino M. Emerging Treatments and Gene Expression
Profiling in High-Risk Medulloblastoma.Paediatr Drugs. 9:81-96, 2007
132. Sardi I, Cetica V, Massimino M, Buccoliero AM, Giunti L, Genitori L, Aricò M.
Promoter methylation and expression analysis of MGMT in advanced pediatric brain
tumors. Oncol Rep. 2009 Oct;22(4):773-9
133. Sardi I, la Marca G, Giovannini MG, Malvagia S, Guerrini R, Genitori L,
Massimino M, Aricò M. Detection of doxorubicin hydrochloride accumulation in the
rat brain after morphine treatment by mass spectrometry. Cancer Chemother
Pharmacol. 2011 Jun;67(6):1333-40.
134. Sardi I, Massimino M, Genitori L, Buccoliero AM, Giangaspero F, Ferrari A.
Intracranial mesenchymal chondrosarcoma: report of two pediatric cases. Pediatr
Blood Cancer. 2011 Apr;56(4):685-6.
135. Satgé D, Stiller CA, Rutkowski S, von Bueren AO, Lacour B, Sommelet D, Nishi
M, Massimino M, Garré ML, Moreno F, Hasle H, Jakab Z, Greenberg M, von der
Weid N, Kuehni C, Zurriaga O, Vicente ML, Peris-Bonet R, Benesch M, Vekemans
M, Sullivan SG, Rickert C. A very rare cancer in Down syndrome: medulloblastoma.
Epidemiological data from 13 countries. J Neurooncol. 2013 Mar;112(1):107-14.
136. Secondino S., Pedrazzoli P., Schiavetto I:, Basilico V., Bramerio E., Massimino
M, Gambacorta M., Siena S.: Antitumor effect of allogeneic hematopoietic SCT in
metastatic medulloblastoma. (Letter) Bone Marrow Transplant 2008; 42: 131-133,
2008
137. Seregni E, Massimino M, Nerini Molteni S, Pallotti F, van der Hiel B, Cefalo G,
Spreafico F, Fossati F, Bombardieri E. Serum and cerebrospinal fluid human
chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell
tumors. Int J Biol Marker 17:112-118, 2002
138. Sevilla J, Schiavello E, Madero L, Pardeo M, Guggiari E, Baragaño M, Luksch R,
Massimino M. Priming of hematopoietic progenitor cells by plerixafor and filgrastim
in children with previous failure of mobilization with chemotherapy and/or cytokine
treatment. J Pediatr Hematol Oncol. 2012 Mar;34(2):146-50.
139. Spreafico F, Massimino M, Gandola L, Cefalo G, Mazza E, Landonio G, Pignoli
E, Poggi G, Terenziani M, Pedrazzoli P, Siena S, Fossati-Bellani F. Survival of
adults treated for medulloblastoma using paediatric protocols. Eur J Cancer
41:1304-1310, 2005
140. Spreafico F, Massimino M, Luksch R, Casanova M, Cefalo CS, Collini P, Ferrari
A, Polastri D, Terenziani M, Gasparini M, Fossati-Bellani F. Intensive, very shortterm chemotherapy for advanced Burkitt's lymphoma in children. J Clin Oncol
20:2783-2788, 2002
141. Spreafico F, Notarangelo LD, Schumacher RF, Savoldi G, Gamba B, Terenziani
M, Collini P, Fasoli S, Giordano L, Luisa B, Porta F, Massimino M, Radice P,
Perotti D.Clinical and molecular description of a Wilms tumor in a patient with
tuberous sclerosis complex. Am J Med Genet A. 2011 Jun;155A(6):1419-24.
142. Spreafico F., Gandola L., Marchianò A., Simonetti F., Poggi G., Adduci A., Clerici
C.A., Luksch R., Biassoni V., Meazza C., Catania S., Terenziani M., Musumeci R.,
Fossati Bellani F., Massimino M Brain magnetic resonance imaging after highdose chemotherapy and radiotherapy for childhood brain tumors. Int J Radiat
Oncol Biol Phys; 70: 1011-1019, 2008
143. Stagno F, Vigneri P, Consoli ML, Cupri A, Stella S, Tambè L, Massimino M,
Manzella L, Di Raimondo F. Hyperdiploidy associated with a high BCR-ABL
transcript level may identify patients at risk of progression in chronic myeloid
leukemia. Acta Haematol. 2012;127(1):7-9. doi: 10.1159/000330607. Epub 2011
Oct 5. No abstract available.
144. Terenziani M, Casalini P, Scaperrotta G, Gandola L, Trecate G, Catania S, Cefalo
G, Conti A, Massimino M, Meazza C, Podda M, Spreafico F, Suman L, Gennaro M.
Occurrence of breast cancer after chest wall irradiation for pediatric cancer, as
detected by a multimodal screening program. Int J Radiat Oncol Biol Phys. 2013
Jan 1;85(1):35-9
145. Terenziani M, Massimino M, Casanova M, Cefalo G, Ferrari A, Luksch R,
Spreafico F, Polastri D, Fontanelli R, Piva L, Fossati-Bellani F. Childhood malignant
ovarian germ cell tumors (MOGCT): a monoinstitutional experience. Gynecologic
Oncology 81: 436-440, 200
146. Terenziani M, Piva L, Spreafico F, Salvioni R, Massimino M, Luksch R, Cefalo G,
Casanova M, Ferrari A, Polastri D, Mazza E, Fossati Bellani F, Nicolai A. Clinical
stage I nonseminomatous germ cell tumors of the testis in childhood and
adolescence: An analysis of 31 cases. J Pediatr Hematol/Oncol 24:454-458, 2002
147. Terenziani M, Spreafico F, Collini P, Meazza C, Massimino M, Piva L.
Endodermal sinus tumor of the vagina. Pediatr Blood Cancer. Pediatr Blood
Cancer. 48:577-8, 2007
148. Terenziani M, Spreafico F, Collini P, Piva L, Perotti D, Podda M, Gandola L,
Massimino M, Cereda S, Cefalo G, Luksch R, Casanova M, Ferrari A, Polastri D,
Valagussa P, Fossati-Bellani F. Adults' Wilms tumor: a monoinstitutional
experience and a review of the literature. Cancer 101:289-293, 2004
Tumori. 2010 Sep-Oct;96(5):684-9
149. Vago C, Bulgheroni S, Usilla A, Biassoni V, Serra A, Gentile S, Ajovalasit D,
Leonardi M, Massimino M, Fidani P, Riva D. Adaptive functioning in children in the
first six months after surgery for brain tumours. Disabil Rehabil. 2011;33(11):95360.
150. Veneroni L, Mariani L, Lo Vullo S, Favini F, Catania S, Vajna de Pava M,
Massimino M, Ferrari A. Symptom interval in pediatric patients with solid tumors:
adolescents are at greater risk of late diagnosis. Pediatr Blood Cancer. 2013
Apr;60(4):605-10
151. Vitellaro M, Ferrari A, Trencheva K, Sala P, Massimino M, Piva L, Bertario L. Is
laparoscopic surgery an option to support prophylactic colectomy in adolescent
patients with Familial Adenomatous Polyposis (FAP)? Pediatr Blood Cancer. 2012
Dec 15;59(7):1223-8.
152. Zacharoulis S, Ashley S, Moreno L, Gentet JC, Massimino M, Frappaz D.
Treatment and outcome of children with relapsed ependymoma: a multi-institutional
retrospective analysis. Childs Nerv Syst. 2010 Jul;26(7):905-11. Epub 2009 Dec 29
153. Zacharoulis S., Ji L., Pollack I.F., Duffner P., Geyer R., Grill J., Schild S., Jaing
T.H., Massimino M., Finlay J., Sposto R.: Metastatic ependymoma: a multiinstitutional retrospective analysis of prognostic factors. Pediatr Blood Cancer 2008;
50: 231-235